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Abstract 
Background: To evaluate the role of thiobarbituric acid reactive substance (TBARS) and nitric oxide (NO) as bio-
chemical biomarkers and central subfield (CST) and cube average thickness (CAT) as biomarkers for medical imaging 
in diabetic retinopathy.
Methods: Forty consecutive cases of diabetic retinopathy and 20 healthy controls were included. Cases were 
divided into two groups: non proliferative diabetic retinopathy (n = 20) and proliferative diabetic retinopathy (n = 20) 
according to ETDRS classification. LogMAR visual acuity was documented. Plasma levels of TBARS, NO and glycated 
hemoglobin (HbA1c) were measured using standard protocol. CST and CAT were analyzed on spectral domain optical 
coherence tomography. Data was analyzed statistically.
Results: Increased severity of diabetic retinopathy was associated with an increase in plasma levels of TBARS 
(F = 10.92; p < 0.001), NO (F = 21.8; p < 0.001) and HbA1c (F = 5.87; p = 0.001). Increase in CST (F = 61.51; p < 0.001) 
and CAT (F = 60.84; p < 0.001) was also found to be associated with increased severity of diabetic retinopathy. Pear-
son’s correlation analysis revealed a positive correlation of TBARS with CST (r = 0.29; p = 0.038) and CAT (r = 0.31; 
p = 0.04). A positive correlation of NO with CST (r = 0.27; p = 0.03) and CAT (r = 0.7; p = 0.001) was also observed. 
On univariate analysis with logMAR visual acuity as dependent variable, a significant increase in visual acuity 
was observed with increase in independent variables TBARS (B = 0.22; p = 0.004), NO (B = 0.006; p < 0.001), CST 
(B = 0.005; p < 0.001) and CAT (B = 0.005; p < 0.001). On multivariate linear regression analysis with logMAR visual 
acuity as dependent variable and adjusting for other factors like duration of diabetes and HbA1c, it was observed 
that increase in independent variables TBARS (B = 0.07), NO (B = 0.001) and CST (B = 0.004) independently predict 
increase in logMAR visual acuity (p < 0.001).
Conclusion: Thiobarbituric acid reactive substance and nitric oxide serve as potential biochemical markers whereas 
central subfield and cube average thickness serve as potential biomarkers for medical imaging for severity of diabetic 
retinopathy. In a clinical retinal setting, CAT and CST will help in early recognition of increase in severity of diabetic 
retinopathy.
Keywords: Thiobarbituric acid reactive substance, Nitric oxide, Oxidative stress, Diabetic retinopathy, Spectral 
domain optical coherence tomography, Central subfield thickness, Cube average thickness
© 2016 Ruia et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
International Journal
of Retina and Vitreous
*Correspondence:  sandeepsaxena2020@yahoo.com 
1 Department of Ophthalmology, King George’s Medical University, 
Lucknow, India
Full list of author information is available at the end of the article
Page 2 of 7Ruia et al. Int J Retin Vitr  (2016) 2:8 
Background
Diabetic retinopathy is the most frequent cause of blind-
ness among adults aged 20–74 years [1]. The number of 
people with diabetes is expected to rise to 300 million 
worldwide by 2025 [2]. Diabetic macular edema resulting 
from blood retinal barrier breakdown (BRB) in diabetic 
retinopathy, is the most common cause of qualitative as 
well as quantitative reduction in health-related quality of 
life [3].
The pathophysiology of DR is complex and theories 
as to the mechanisms involved come from cell culture 
experiments and animal models. From experimental 
data, an understanding of what might happen in humans 
is proposed. The high content of polyunsaturated fatty 
acids, high oxygen uptake and glucose oxidation rela-
tive to any other tissue, renders the retina more suscep-
tible to oxidative stress [4]. Increased concentration of 
reactive oxygen species (ROS) is considered as a causal 
link between hyperglycemia and diabetic complication 
through various metabolic pathways. These include the 
polyol pathway [5], the advanced glycation end product 
(AGE) pathway [6], protein kinase C (PKC) pathway [7, 
8] alteration in the expressions of vascular endothelial 
growth factor (VEGF) [9] and mitochondrial dysfunc-
tions [10]. These pathways trigger further production 
of ROS and subsequent lipid peroxidation, resulting in 
amplified tissue damage [11].
Irreversible accumulation of AGE occurs within reti-
nal capillary cells in the later stages of retinopathy. AGE 
lead to the activation of nuclear transcriptional factor, 
NF-kB, by generating ROS [12]. NF-kB activation triggers 
a pro-apoptotic program in retinal pericytes [13]. ROS 
mediated activation of PKC leads to increasing vessel 
permeability, endothelial proliferation and apoptosis, via 
upregulation of angiogenic factor VEGF [14]. Inhibition 
of PKC activation is shown to prevent diabetes-induced 
oxidative stress [15, 16]. Altered gene profile of scaveng-
ing enzymes in retinal pericytes obtained from diabetic 
patients, correlates with the over expression of the cell 
death protease gene, suggesting an important role of oxi-
dative stress in pericyte loss seen in diabetic retinopathy 
[17]. Damage to the mitochondrial lipid membrane by 
ROS increases the permeability of the organelle, resulting 
in increased apoptosis of retinal capillary cells [12].
Hyperglycemia induced expression of nitric oxide syn-
thase (eNOS) and superoxide anions (O2−) by endothe-
lial cells has been observed in vitro [18]. AGE initiate a 
sequence of events leading to retinal capillary cell apop-
tosis via activation of NF-kB [19]. NF-kB modulates the 
expression of inducible nitric oxide synthase (iNOS), 
resulting in increased ROS production [20]. Nitric oxide 
(NO) is instrumental in vasodilation of retinal vessels in 
diabetic retinopathy. Reaction between superoxide (ROS) 
and NO forms peroxynitrite (ONOO−) and reduces the 
bioavailability of NO. Elevated peroxynitrite levels in 
circulation have been documented in diabetics and is 
known to cause endothelial dysfunction [21]. Caspases, a 
group of cysteine proteases that are essential for mediat-
ing apoptosis in cells [22], are known to be very sensitive 
toward oxidative and nitrative stress [23]. Caspase-3 is 
activated in the retina in diabetes, and the therapy that 
inhibits the development of retinopathy in diabetic rats 
also inhibits retinal caspase-3 activation [24].
Reliable, reproducible quantitative estimation of dia-
betic macular edema has been realized with advent of 
spectral domain optical coherence tomography (SD-
OCT). Macular thickness parameters on SD-OCT have 
been well correlated with severity of diabetic retinopathy 
[25]. Biomarkers are defined as anatomical, biochemi-
cal, molecular parameters or imaging features used for 
refinement of diagnosis, measuring progress of disease or 
predict or monitor effects of treatment. They are meas-
ured by laboratory assay, physical examination or medi-
cal imaging. Their source can be tissue or body fluid such 
as serum/plasma, urine, synovial fluid or tissue biopsy 
[26]. Imaging biomarkers have the benefit of targeting the 
disease focus in comparison to biochemical biomarkers 
which tend to integrate information from entire body. 
Earlier studies have documented the possible role of oxi-
dative and nitrative stress markers, and role of OCT in 
identifying subclinical macular edema as biomarkers in 
diabetic retinopathy [27]. However, these studies have 
not correlated the biomarkers in serum with biomarkers 
of medical imaging.
The purpose of our study was to correlate the serum 
biomarkers, TBARS and NO with biomarkers for medi-
cal imaging, CAT and CST. The objectives of our study 
were: (1) to assess the potential role of thiobarbituric acid 
reactive substance (TBARS) and nitric oxide (NO) as bio-
chemical biomarkers whereas central subfield (CST) and 
cube average thickness (CAT) as biomarkers for medical 
imaging for diabetic retinopathy, (2) to identify the role 
of these biomarkers as predictors of visual impairment in 
diabetic retinopathy.
Methods
Our study had institutional review board clearance from 
ethics committee of King George Medical university, 
Lucknow, Uttar Pradesh, India. The study was performed 
in accordance to the tenets of the Helsinki declaration. 
Tertiary care center based prospective cross sectional 
study, where 40 consecutive cases and 20 healthy controls 
were included after obtaining informed voluntary con-
sent. These 40 cases were divided into non proliferative 
diabetic retinopathy (NPDR; n  =  20) and proliferative 
diabetic retinopathy (PDR; n = 20) on the basis of Early 
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treatment diabetic retinopathy study (ETDRS) classifica-
tion [28]. Non diabetic individuals presenting for refrac-
tion were included as controls. Cases with ocular diseases 
which could affect the retinal vascular pathology (hyper-
tensive retinopathy), any previous ophthalmic surgical or 
laser interventions, fluorescein angiography suggestive 
of ischemic maculopathy, end stage renal disease, cases 
with signal strength 5 or below on OCT examination and 
cases taking any mineral supplements or antioxidants 
were excluded from the study. Best-corrected visual acu-
ity was documented in logMAR scale. Slit lamp biomi-
croscopic and dilated ophthalmoscopic examination was 
performed. Digital fundus photography and fluorescein 
angiography were performed using Zeiss fundus camera 
FF 450 Plus with pixel width of 0.0054 and image size 
2588 × 1958 (Carl Zeiss Meditec AG, Jena, Germany).
Blood samples from study subjects were drawn by 
aseptic vein puncture and transferred into tubes con-
taining 3.89  % trisodium citrate (in the ratio of 9:1) for 
separation of plasma. The parameters for measure of oxi-
dative stress were TBARS and NO. Glycated hemoglobin 
(HbA1c) was measured on autoanalyser using standard 
protocol.
Assay of lipid peroxidation As a measure of lipid per-
oxidation, malonaldehyde formation was estimated 
using the level of thiobarbituric acid reactive substances 
following the method of Ohkawa et  al. [29]. The results 
are expressed as nmMDA/ml. Thiobarbituric acid was 
procured from Sigma-Aldrich, St. Louis, Missouri, USA. 
Other chemicals required such as ethylene diamine tetra 
acetic acid and trichloroacetic acid were procured from 
Merck, Mumbai, India.
Assay of nitric oxide Levels of NO in plasma were 
determined using the nitric oxide ELISA kit available 
commercially (Calbiochem, San Diego, USA) [30]. The 
results are expressed as µmoles/liter.
Macular thickness measurements Every study subject 
underwent imaging of the fundus using macular cube 
512x128 feature of Cirrus High Definition SD-OCT (Carl 
Zeiss Meditec Inc., CA, USA). CST and CAT were docu-
mented in µm. CST was defined as thickness of the cen-
tral circle in the circular map known as the ETDRS Grid. 
CAT was defined as an overall average thickness for the 
internal limiting membrane-retinal pigment epithelium 
tissue layer over the entire 6 × 6 mm square scanned area 
(Fig. 1).
Statistical analysis
Data is summarized and presented as Mean  ±  SE. Chi 
square (χ2) test analyzed the difference in gender distri-
bution between the groups. One way analysis of variance 
(ANOVA) was done to compare the values of TBARS, 
NO, CST, CAT and HbA1c between the study groups 
control, NPDR and PDR. The mean values were found 
to be significantly different between the groups, hence 
post hoc test (Fisher’s  least significant difference) were 
done to find the difference between control and NPDR, 
control and PDR, NPDR and PDR. Pearson’s correlation 
coefficient (r) was found to analyze the correlation of the 
continuous variables TBARS, NO with CAT and CST. 
Univariate followed by multivariate linear regression 
analysis was done taking visual acuity as a dependent 
variable with TBARS, NO, CST and CAT as independ-
ent variables, and adjusted for duration of diabetes and 
HbA1c. p  <  0.05 was considered statistically significant. 
All analyses were performed using SPSS software (win-
dow version 21.0).
Results
The mean age was 54  ±  1.48  years in controls, 
53.5  ±  2.68  years in NPDR and 56.2  ±  4.12  years in 
PDR group. No statistically significant difference existed 
between the cases and controls (F = 0.41; p > 0.05). The 
male and female ratio in different groups was 13 males and 
7 females in controls, 12 males and 8 females in NPDR and 
10 males and 10 females in PDR. No statistically significant 
difference existed in gender distribution between the cases 
and controls (χ2 = 0.42; p > 0.05). The mean duration of 
diabetes (years) in NPDR group was 8.2 ± 2.3 and in PDR 
group 11.4 ± 4.1. Mean logMAR visual acuity, CST, CAT 
and plasma levels of TBARS, NO, HbA1c among the study 
groups are summarized in Table 1.
Fig. 1 a Horizontal cross section scan of spectral domain optical 
coherence tomography illustrating diabetic macular edema (yellow 
arrow). b Color coded internal limiting membrane-retinal pigment 
epithelium thickness overlay map of 6X6 square mm macular cube. 
c Early treatment diabetic retinopathy study (ETDRS) grid map with 
numerical data for central subfield retinal thickness within innermost 
circle (red arrow) as well as average macular thickness
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ANOVA revealed significant increase in levels of 
TBARS (F = 10.92; p < 0.001), NO (F = 21.8; p < 0.001) 
and HbA1c (F = 5.87; p = 0.001) with increase in severity 
of diabetic retinopathy (Figs. 2, 3). LogMAR visual acuity 
(F =  84.72; p < 0.001), CAT (F =  60.84; p < 0.001) and 
CST (F =  61.51; p < 0.001) were also found to increase 
with severity of diabetic retinopathy.
Pearson’s correlation analysis revealed a positive corre-
lation of TBARS with CST (r = 0.29; p = 0.038) and CAT 
(r  =  0.31; p  =  0.04) (Figs.  4, 5). A positive correlation 
of NO with CST (r = 0.27; p = 0.03) and CAT (r = 0.7; 
p = 0.001) was also observed (Figs. 6, 7).
Table 1 Summary of Mean ± SD of study variables among study groups along with correlation on ANOVA
Variable Groups F value + (3,76 DF) p value
Controls (n = 20) NPDR (n = 20) PDR (20)
LogMAR Visual acuity 0.08 ± 0.02 0.75 ± 0.07 1.29 ± 0.07 84.72 <0.001
Central subfield thickness (µm) 249.30 ± 5.22 321.45 ± 24.25 319.03 ± 18.64 60.84 <0.001
Cube average thickness (µm) 258.93 ± 2.45 334.90 ± 10.47 335.45 ± 7.46 61.5 <0.001
TBARS (nmMDA/ml) 1.98 ± 0.15 3.11 ± 0.22 3.01 ± 0.23 10.92 <0.001
NO (µmoles/liter) 62.46 ± 13.09 109.72 ± 13.27 154.25 ± 11.77 21.8 <0.001
Glycated hemoglobin (% of total hemoglobin) 5.8 ± 0.78 7.6 ± 0.67 8.3 ± 1.1 5.87 0.001
Fig. 2 Box and whisker plot illustrating plasma levels of thiobarbituric 
acid reactive substances among study groups. NPDR non proliferative 
diabetic retinopathy, PDR proliferative diabetic retinopathy
Fig. 3 Box and whisker plot illustrating plasma levels of nitric oxide 
among study groups. NPDR non proliferative diabetic retinopathy, 
PDR proliferative diabetic retinopathy
Fig. 4 Scatter plot illustrating plasma levels of thiobarbituric acid 
reactive substances and cube average thickness among the study 
groups
Fig. 5 Scatter plot illustrating plasma levels of thiobarbituric acid 
reactive substances and central subfield thickness among the study 
groups
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On univariate analysis with logMAR visual acuity as 
dependent variable and TBARS, NO, CST, CAT as inde-
pendent variables, a significant increase in visual acu-
ity was observed with increase in TBARS (B  =  0.22; 
p = 0.004), NO (B = 0.006; p < 0.001), CST (B = 0.005; 
p < 0.001) and CAT (B = 0.005; p < 0.001). On multivari-
ate linear regression analysis with logMAR visual acu-
ity as dependent variable and TBARS, NO, CST, CAT 
as independent variables and adjusting for other factors 
like duration of diabetes and HbA1c, it was observed that 
increase in TBARS (B = 0.07), NO (B = 0.001) and CST 
(B  =  0.004) independently predict increase in logMAR 
visual acuity (p < 0.001) (Table 2) (Figs. 8, 9, 10).
Discussion
In the present study, a significant positive correlation of 
TBARS and nitric oxide levels in plasma, was observed 
with CST and CAT on imaging in diabetic retinopathy.
Significantly raised plasma levels of thiobarbituric acid 
reactive substances and metabolites of nitric oxide have 
Fig. 6 Scatter plot illustrating plasma levels of nitric oxide and cube 
average thickness among the study groups
Fig. 7 Scatter plot illustrating plasma levels of nitric oxide and central 
subfield thickness among the study groups
Table 2 Univariate linear regression analysis taking vis-
ual acuity as  a dependent variable with  TBARS, NO, CST 
and  CAT as  independent variables followed by  multivari-




logMar visual acuity as dependent variable
Univariate analysis Multivariate 
analysis (adjusted) 
(r2 = 0.96)
B p B p
TBARS 0.22 0.004 0.07 <0.001
NO 0.006 <0.001 0.001 0.001
CST 0.005 <0.001 0.004 <0.001
CAT 0.005 <0.001 0.001 0.41
Fig. 8 Scatter plot illustrating plasma levels of thiobarbituric acid 
reactive substances and logMAR visual acuity among the study 
groups
Fig. 9 Scatter plot illustrating plasma levels of nitric oxide and log-
MAR visual acuity among the study groups
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been documented in patients of diabetic retinopathy 
[31, 32]. Izumi et  al. found an increase in plasma levels 
of nitric oxide in patients with diabetes with or without 
DR in comparison to patients with no diabetes mellitus. 
Ozden et  al. documented a significant increase in the 
serum levels of nitric oxide with increased severity of dia-
betic retinopathy [33]. Attenuation of oxidative and nitra-
tive stress by anti-oxidant treatment in diabetic animals 
further corroborate these findings [34, 35]. Hartnett et al. 
published the possible role of oxidative stress markers 
including TBARS in predicting, diagnosing and prevent-
ing DR.
Endothelial damage due to accumulation of AGEs, acti-
vation of PKC, increased expression of VEGF and intra-
cellular adhesion molecule (ICAM-1), increase in ROS 
leads to breakdown of BRB resulting in diabetic macular 
edema [36–39]. Studies on streptozocin induced diabetic 
rats have associated increased expression of endothe-
lial NOS with BRB breakdown [40]. Our study found a 
positive correlation between the serum levels of TBARS, 
NO and CAT and CST on imaging. Subclinical macular 
edema identified by OCT has been suggested as potential 
organ-specific biomarkers of DR [27].
Retinal expression of VEGF is elevated by ROS [14]. 
Increased expression of VEGF has been documented to 
increase expression of NOS [40]. Formation of perox-
ynitrite due to reaction between ROS and nitric oxide 
further causes endothelial dysfunction [41]. Damage 
to the mitochondrial lipid membrane by ROS, result 
in increased apoptosis of retinal capillary cells [42]. 
Increase nitrative stress in the retinal vascular cells via 
activation of NF-kB by AGEs also lead to apoptosis of 
retinal pericytes [19]. Increased plasma levels of nitroty-
rosine, another reactive nitrogen species, in type 2 dia-
betic patients were observed to have a significant positive 
correlations with plasma levels of ICAM-1 [43, 44]. In 
our previous study, increase in serum levels of VEGF and 
ICAM-1 with increase in severity of diabetic retinopathy 
was documented [45]. In a recent study, we documented 
an increase in structural alterations in outer retina with 
increase in oxidative and nitrative stress in diabetic retin-
opathy [46].
Conclusion
In the present study, TBARS and NO were found to 
increase with the severity of retinopathy. TBARS and NO 
serve as potential biochemical biomarkers. Similar obser-
vations were obtained with CST and CAT. In a clinical 
retinal setting, CST and CAT serve as potential biomark-
ers for medical imaging for early recognition of increase 
in severity of diabetic retinopathy. Significant correla-
tion between TBARS, NO and CST and CAT was recog-
nized. TBARS, NO and CST would serve as significant 
indicators for prognosticating visual outcome in diabetic 
retinopathy.
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